Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03945422 · ClinicalTrials.gov registry record · NA
The Use of RF in Premature Jowl and Neck Laxity Following Facialplasty
A NA study of Premature Jowl and Neck Laxity Following Facialplasty, sponsored by InMode MD.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
- 1
- Study location
NCT03945422: Completed NA study of Premature Jowl and Neck Laxity Following Facialplasty, sponsored by InMode MD.
NCT03945422 is a NA study of Premature Jowl and Neck Laxity Following Facialplasty that has completed, run by InMode MD. The registered enrollment target is 11 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03945422, a NA study of Premature Jowl and Neck Laxity Following Facialplasty, has completed, sponsored by InMode MD.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
- 1
- Study location
Study Summary
Study is to evaluate the efficacy of treatment Radio Frequency in premature jowl and neck laxity following facialplasty
Primary Outcome
Photos from all time points (baseline and follow-up visits) will be evaluated by the treating physician and 2 independent evaluators.
Conditions Studied
Interventions
- DEVICE AccuTite/FaceTite
Study Locations (1)
Illinois
- Chicago Center for Facial Plastics - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2019-04-15 |
| Est. Completion | 2021-01-18 |
| Phase | NA |
What the finished NCT03945422 record still lists
NCT03945422 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Premature Jowl and Neck Laxity Following Facialplasty appearing as the primary indexed condition, and to 1 intervention - of which AccuTite/FaceTite is the first listed.
NCT03945422 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT03945422 about?
NCT03945422 is a clinical study titled "The Use of RF in Premature Jowl and Neck Laxity Following Facialplasty". Study is to evaluate the efficacy of treatment Radio Frequency in premature jowl and neck laxity following facialplasty
What is the current status of trial NCT03945422?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2019-04-15. Estimated completion is 2021-01-18.
What conditions does trial NCT03945422 study?
This clinical trial studies the following conditions: Premature Jowl and Neck Laxity Following Facialplasty.
What interventions are being tested in trial NCT03945422?
The interventions under investigation include: AccuTite/FaceTite (DEVICE).
Who is sponsoring clinical trial NCT03945422?
This trial is sponsored by InMode MD, which has 22 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03945422 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03945422's enrollment target sits among peer trials
11 1927th of 2000 higher than 74 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI